The Antibiotics Editorial Office retracts the paper “The Discovery of Novel Antimicrobial Agents through the Application of Isocyanide-Based Multicomponent Reactions” [1], cited above.
Following publication, concerns were brought to the attention of the publisher regarding the authenticity of the authorship of this article [1].
Adhering to our complaint procedure, an investigation was conducted by the Editorial Office and Editorial Board. Following communications with the authorship group, the Editorial Board were unable to verify the identity, contribution, or affiliations of a number of the authors listed on this manuscript, nor could the origins of the study be confirmed. As a consequence, the Editorial Board has lost confidence in the integrity of the findings and has decided to retract this publication [1] as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the journal Antibiotics.
The corresponding author, Sameer Quazi, agreed to the retraction. Maliha Tabassum Rashid and Javid Ahmad Malik wish to indicate that they were not aware of this submission nor consented to its publication. Shreelaxmi Gavas did not provide a comment on this decision.
Reference
- Quazi, S.; Rashid, M.T.; Malik, J.A.; Gavas, S. RETRACTED: The Discovery of Novel Antimicrobial Agents Through the Application of Isocyanide-Based Multicomponent Reactions. Antibiotics 2023, 12, 849. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).